Michael F. Holick, MD, PhD

Director, Bone Health Care Clinic

Michael Holick
85 E. Newton St Fuller Building


Dr. Holick has made numerous contributions to the field of the biochemistry, physiology, metabolism, and photobiology of vitamin D for human nutrition. Dr. Holick has established global recommendations advising sunlight exposure as an integral source of vitamin D. He has helped increase awareness in the pediatric and medical communities regarding vitamin D deficiency pandemic, and its role in causing not only metabolic bone disease, and osteoporosis in adults, but increasing risk of children and adults developing preeclampsia, common deadly cancers, schizophrenia, infectious diseases including TB and influenza, autoimmune diseases including type 1 diabetes and multiple sclerosis, type 2 diabetes, stroke and heart disease.

Dr. Holick is a Diplomate of the American Board of Internal Medicine, a Fellow of the American College of Nutrition, and a member of the American Association of Physicians. He is the recipient of numerous awards and honors, including the General Clinical Research Centers Program Award for Excellence in Clinical Research from NIH, American College of Nutrition’s Communication Media Award, Best Docs in America, the Linus Pauling Functional Medicine Award from the Institute for Functional Medicine and the Linus Pauling Prize for Human Nutrition. Dr. Holick serves on a number of national committees and editorial boards and has organized and/or co-chaired several international symposia. He served as the chair for the Endocrine Society’s Practice Guidelines on Vitamin D. He has authored more than 400 peer-reviewed publications, and written more than 200 review articles, as well as numerous book chapters. He has acted as editor and/or co-editor on 13 books, and has written The UV Advantage in 2004 and The Vitamin D Solution in 2010 and helped develop the dminder.info app.

Other Positions

  • Director, General Clinical Research Unit, Boston University Medical Campus
  • Professor, Endocrinology, Diabetes, Nutrition & Weight Management, Medicine, Boston University School of Medicine
  • Director of the Vitamin D, Skin and Bone Research Laboratory, Endocrinology, Diabetes, Nutrition & Weight Management, Medicine, Boston University School of Medicine
  • Professor, Physiology & Biophysics, Boston University School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences


  • University of Wisconsin-Madison, MD
  • University of Wisconsin-Madison, PhD
  • University of Wisconsin-Madison, MS
  • Seton Hall University, BS

Classes Taught

  • GMSNU755
  • GMSNU757


  • Published on 3/8/2021

    Charoenngam N, Shirvani A, Reddy N, Vodopivec DM, Apovian CM, Holick MF. Association of vitamin D status with hospital morbidity and mortality in adult hospitalized COVID-19 patients. Endocr Pract. 2021 Mar 08. PMID: 33705975.

    Read at: PubMed
  • Published on 3/1/2021

    Nimitphong H, Guo W, Holick MF, Fried SK, Lee MJ. Vitamin D Inhibits Adipokine Production and Inflammatory Signaling Through the Vitamin D Receptor in Human Adipocytes. Obesity (Silver Spring). 2021 Mar; 29(3):562-568. PMID: 33624437.

    Read at: PubMed
  • Published on 2/8/2021

    Karamizadeh M, Seif M, Holick MF, Akbarzadeh M. Developing a Model for Prediction of Serum 25-Hydroxyvitamin D Level: The Use of Linear Regression and Machine Learning Methods. J Am Coll Nutr. 2021 Feb 08; 1-10. PMID: 33555236.

    Read at: PubMed
  • Published on 11/27/2020

    Cocate PG, Kac G, Hieitmann BL, Nadanovsky P, da Veiga Soares Carvalho MC, Benaim C, Schlüssel MM, de Castro MBT, Alves-Santos NH, Baptista AF, Holick MF, Mokhtar RR, Bomfim AR, Adegboye ARA. Correction to: Calcium and vitamin D supplementation and/or periodontal therapy in the treatment of periodontitis among Brazilian pregnant women: protocol of a feasibility randomised controlled trial (the IMPROVE trial). Pilot Feasibility Stud. 2020 Nov 27; 6(1):187. PMID: 33292810.

    Read at: PubMed
  • Published on 10/7/2020

    Jain SK, Parsanathan R, Levine SN, Bocchini JA, Holick MF, Vanchiere JA. The potential link between inherited G6PD deficiency, oxidative stress, and vitamin D deficiency and the racial inequities in mortality associated with COVID-19. Free Radic Biol Med. 2020 12; 161:84-91. PMID: 33038530.

    Read at: PubMed
  • Published on 9/25/2020

    Maghbooli Z, Sahraian MA, Ebrahimi M, Pazoki M, Kafan S, Tabriz HM, Hadadi A, Montazeri M, Nasiri M, Shirvani A, Holick MF. Vitamin D sufficiency, a serum 25-hydroxyvitamin D at least 30 ng/mL reduced risk for adverse clinical outcomes in patients with COVID-19 infection. PLoS One. 2020; 15(9):e0239799. PMID: 32976513.

    Read at: PubMed
  • Published on 9/17/2020

    Kaufman HW, Niles JK, Kroll MH, Bi C, Holick MF. SARS-CoV-2 positivity rates associated with circulating 25-hydroxyvitamin D levels. PLoS One. 2020; 15(9):e0239252. PMID: 32941512.

    Read at: PubMed
  • Published on 9/9/2020

    Slominski RM, Stefan J, Athar M, Holick MF, Jetten AM, Raman C, Slominski AT. COVID-19 and Vitamin D: A lesson from the skin. Exp Dermatol. 2020 09; 29(9):885-890. PMID: 32779213.

    Read at: PubMed
  • Published on 9/1/2020

    Holick MF. A call for action: standard of care guidelines to assess vitamin D status are needed for patients with hip fracture. Am J Clin Nutr. 2020 09 01; 112(3):507-509. PMID: 32710753.

    Read at: PubMed
  • Published on 8/20/2020

    Kimball SM, Holick MF. Official recommendations for vitamin D through the life stages in developed countries. Eur J Clin Nutr. 2020 11; 74(11):1514-1518. PMID: 32820241.

    Read at: PubMed

View 589 more publications: View full profile at BUMC

View all profiles